Literature DB >> 19868143

EXPERIMENTAL STUDIES UPON LYMPHOCYTES : II. THE ACTION OF IMMUNE SERA UPON LYMPHOCYTES AND SMALL THYMUS CELLS.

A M Pappenheimer1.   

Abstract

The work of previous investigators gives the impression that it is easy to produce sera which both in vitro and upon injection are leukotoxic. At the same time the specificity of these leukotoxic sera for the particular type of cell used as antigen, and even for leukocytes in general, has been doubtful. The methods used have made certain possible factors of error unavoidable. Even careful washing of an organ or suspension cannot render it wholly blood-free, so that it is not surprising that the sera should be moderately hemolytic and hemagglutinative. Pearce has shown that the injection of very small amounts of blood is sufficient to evoke the production of immune hemolysins. When such sera are injected the lesions, as Pearce states, may be due in part to the production of hemagglutinative thrombi, although this hardly seems to apply to the changes in lymphoid tissue described by Flexner. On the other hand, the lymphotoxic effect of hemolytic sera may be due to the lymphocytes injected with the red cells. Our own experiments indicate that the lymphotoxic and agglutinative factors are to a considerable degree distinct from the hemolytic and hemagglutinative ones, since they can be separated from one another by absorption. Further evidence is presented that the small thymus cells are biologically related to, if not identical with the lymphocytes derived from lymph glands.

Entities:  

Year:  1917        PMID: 19868143      PMCID: PMC2125644          DOI: 10.1084/jem.26.2.163

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  [On the problem of antibody specificity of heterologous antilymphocyte serum].

Authors:  A Fateh-Moghadam; M Knedel; R Pichlmayr; C Morell
Journal:  Klin Wochenschr       Date:  1968-10-15

2.  [In vitro test of the antilymphocyte serum (AS) using the leukocyte resistance test].

Authors:  J Schröder
Journal:  Klin Wochenschr       Date:  1970-07-01

3.  The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions.

Authors:  Y Iwasaki; K A Porter; J R Amend; T L Marchioro; V Zühlke; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1967-01

4.  Flame retardant tris(1,3-dichloro-2-propyl)phosphate (TDCPP) toxicity is attenuated by N-acetylcysteine in human kidney cells.

Authors:  David W Killilea; Darryl Chow; Sheng Qi Xiao; Charles Li; Marshall L Stoller
Journal:  Toxicol Rep       Date:  2017-05-17

5.  Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera.

Authors:  R D Guttmann; C B Carpenter; R R Lindquist; J P Merrill
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

6.  The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type.

Authors:  B H WAKSMAN; S ARBOUYS; B G ARNASON
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

7.  The effect of heterologous anti-lymphocyte seerum on mouse hemopoietic stem cells.

Authors:  T R DeMeester; N D Anderson; C F Shaffer
Journal:  J Exp Med       Date:  1968-04-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.